{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:40:01Z","timestamp":1749634801961,"version":"3.41.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[1999,1,1]],"date-time":"1999-01-01T00:00:00Z","timestamp":915148800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Neurooncol"],"published-print":{"date-parts":[[1999,1]]},"DOI":"10.1023\/a:1006346624083","type":"journal-article","created":{"date-parts":[[2002,12,22]],"date-time":"2002-12-22T01:36:27Z","timestamp":1040520987000},"page":"37-46","source":"Crossref","is-referenced-by-count":7,"title":["Increased Phosphorylation of DNA Topoisomerase II in Etoposide Resistant Mutants of Human Glioma Cell Line"],"prefix":"10.1007","volume":"45","author":[{"given":"Y.","family":"Matsumoto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Kunishio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Nagao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"253401_CR1","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1007\/BF00684858","volume":"34","author":"WT Beck","year":"1994","unstructured":"Beck WT, Kim R, Chen M: Novel actions of inhibitors of DNA topoisomerase II in drug-resistant tumor cells. Cancer Chemother Pharmacol 34(Suppl): S14\u2013S18, 1994","journal-title":"Cancer Chemother Pharmacol"},{"key":"253401_CR2","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","volume":"84","author":"AT Fojo","year":"1987","unstructured":"Fojo AT, Ueda K, Slamon DJ, Poplack DG, Gottesman MM, Pastan I: Expression of a multidrug resistance gene in human tumors and tissues. Proc Natl Acad Sci USA 84: 265\u2013269, 1987","journal-title":"Proc Natl Acad Sci USA"},{"key":"253401_CR3","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1126\/science.1360704","volume":"258","author":"SPC Cole","year":"1992","unstructured":"Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AJ, Kurz EU, Duncan AMV, Deeley RG: Overexpression of a transporter gene in a multidrug resistant human lung cancer cell line. Science 258: 1650\u20131654, 1992","journal-title":"Science"},{"key":"253401_CR4","first-page":"5902","volume":"54","author":"SPC Cole","year":"1994","unstructured":"Cole SPC, Sparks KE, Fraser K, Loe DW, Grant CE, Wilson GM: Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. Cancer Res 54: 5902\u20135910, 1994","journal-title":"Cancer Res"},{"key":"253401_CR5","first-page":"357","volume":"54","author":"CE Grant","year":"1994","unstructured":"Grant CE, Vadimarsson G, Hipfner DR, Almquist KC, Cole SPC, Deeley RG: Overexpression of multidrug resistance associated protein increases resistance to natural product drugs. Cancer Res 54: 357\u2013361, 1994","journal-title":"Cancer Res"},{"key":"253401_CR6","first-page":"4352","volume":"55","author":"A Lorico","year":"1995","unstructured":"Lorico A, Rappa G, Srimatkandada S, Catapano CV, Fernandes DJ, Germino JF, Sartorelli AC: Increased rate of VP-16 efflux in a murine leukemia cell line overexpressing the multidrug associated protein gene. Cancer Res 55: 4352\u20134360, 1995","journal-title":"Cancer Res"},{"key":"253401_CR7","first-page":"59","volume":"11","author":"Y Matsumoto","year":"1994","unstructured":"Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchi da T, Nagao S: Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11. Brain Tumor Pathol 11: 59\u201364, 1994","journal-title":"Brain Tumor Pathol"},{"key":"253401_CR8","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1182\/blood.V83.2.517.517","volume":"83","author":"SH Kaufmann","year":"1994","unstructured":"Kaufmann SH, Karp JE, Jones RJ, Miller CB, Schneider E, Zwelling LA, Cowan K, Wendel K, Burke PJ: Topoisomerase II levels and drug sensitivity in adult acte myelogenous leukemia. Blood 83: 517\u2013530, 1994","journal-title":"Blood"},{"key":"253401_CR9","first-page":"3951","volume":"51","author":"H Takano","year":"1991","unstructured":"Takano H, Kohno K, Ono M, Ushida Y, Kuwano M: Increased phosphorylation of DNA topoisomerase II in etoposide resistant mutants of human cancer KB cells. Cancer Res 51: 3951\u20133957, 1991","journal-title":"Cancer Res"},{"key":"253401_CR10","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/j.1460-2075.1992.tb05230.x","volume":"11","author":"ME Cardenas","year":"1992","unstructured":"Cardenas ME, Dang Q, Glover CVC, Gasser SM. Casein kinase II phosphorylates the eukaryote-specific c-terminal domain of topoisomerase II in vitro. EMBO J 11: 1785\u20131796, 1992","journal-title":"EMBO J"},{"key":"253401_CR11","doi-asserted-by":"crossref","first-page":"28357","DOI":"10.1074\/jbc.270.47.28357","volume":"269","author":"NJ Wells","year":"1995","unstructured":"Wells NJ, Fry AM, Guano F, Norbury C, Hickson ID: Cell cycle phase-specific phosphorylatioin of human topoisomerase II?. J Biol Chem 269: 28357\u201328363, 1995","journal-title":"J Biol Chem"},{"key":"253401_CR12","first-page":"563","volume":"40","author":"GC Alghisi","year":"1994","unstructured":"Alghisi GC, Roberts E, Cardenas ME, Gasser SM: The regulation of DNA Topoisomerase II by Casein Kinase II. Cell Mol Biol Res 40: 563\u2013571, 1994","journal-title":"Cell Mol Biol Res"},{"key":"253401_CR13","first-page":"2","volume-title":"Molecular Biology ofDNATopoisomerases and its Application to Chemotherapy","author":"PR Caron","year":"1993","unstructured":"Caron PR, Wang JC: DNA topoisomerase as target of therapeutics: a structural overview. In: Andoh T, Ikade H, Oguro M(eds). Molecular Biology ofDNATopoisomerases and its Application to Chemotherapy. CRC Press Inc, Boca Raton, 1993, pp 2\u201318"},{"key":"253401_CR14","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/jnci\/82.13.1107","volume":"82","author":"P Skehan","year":"1990","unstructured":"Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S, Boyd MR: New colorimetric cytotoxicty assay for anticancer-drug screening. J Natl Cancer Inst 82: 1107\u20131112, 1990","journal-title":"J Natl Cancer Inst"},{"key":"253401_CR15","doi-asserted-by":"crossref","first-page":"7035","DOI":"10.1093\/nar\/12.18.7035","volume":"12","author":"DA Melton","year":"1984","unstructured":"Melton DA, Krieg PA, Rebagliati MR, Maniatis T, Zinn K, Green MR: Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing a bacteriophage SP6 promoter. Nucleic Acids Res 12: 7035\u20137056, 1984","journal-title":"Nucleic Acids Res"},{"key":"253401_CR16","doi-asserted-by":"crossref","first-page":"18031","DOI":"10.1016\/S0021-9258(19)84675-6","volume":"264","author":"LA Mickley","year":"1989","unstructured":"Mickley LA, Bates SE, Richert ND, Currier S, Tanaka S, Foss F, Rosen N, Fojo AT: Modulation of the expression of a multidrug resistance gene (mdr-1\/P-glycoprotein) by differentiating agents. J Biol Chem 264: 18031\u201318040, 1989","journal-title":"J Biol Chem"},{"key":"253401_CR17","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jso.2930530210","volume":"53","author":"Y Matsumoto","year":"1993","unstructured":"Matsumoto Y, Fujiwara T, Honjo Y, Sasaoka N, Tsuchida T, Nagao S: Quantitative analysis of DNA topoisomerase I activity in human and rat glioma: characterization and mechanism of resistance to antitopoisomerase chemical, camptothecin-11. J Surg Oncol 53: 97\u2013103, 1993","journal-title":"J Surg Oncol"},{"key":"253401_CR18","first-page":"4729","volume":"51","author":"M Hinds","year":"1991","unstructured":"Hinds M, Deisseroth K, Mayes J, Altschuler E, Jansen R, Ledley FD, Zwelling LA: Identification of a point in the topoisomerase II gene from a human leukemia cell line containing an amsacrine-resistant form of topoisomerase II. Cancer Res 51: 4729\u20134731, 1991","journal-title":"Cancer Res"},{"key":"253401_CR19","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1038\/379225a0","volume":"379","author":"JC Berger","year":"1996","unstructured":"Berger JC, Gamblin SJ, Harrison SC, Wang JC: Structure and mechanism of DNA topoisomerase II. Nature 379: 225\u2013232, 1996","journal-title":"Nature"},{"key":"253401_CR20","first-page":"6962","volume":"14","author":"YS Vassetzky","year":"1994","unstructured":"Vassetzky YS, Dang QI, Benedetiti P, Gasser SM: Topoisomerase II forms multimer in vitro: effects of metals, ?-glycerophosphate, and phosphorylation of its c-terminal domain. Mol Cell Biol 14: 6962\u20136974, 1994","journal-title":"Mol Cell Biol"},{"key":"253401_CR21","doi-asserted-by":"crossref","first-page":"29746","DOI":"10.1016\/S0021-9258(18)43944-0","volume":"270","author":"NJ Wells","year":"1994","unstructured":"Wells NJ, Addison CM, Fry AM, Ganapathi R, Hickson ID: Serine 1524 is a major site of phosphorylation on human topoisomerase IIa protein in vivo and is a substrate for casein kinase II in vitro. J Biol Chem 270: 29746\u201329751, 1994","journal-title":"J Biol Chem"},{"key":"253401_CR22","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1042\/bj3030681","volume":"303","author":"PM Watt","year":"1994","unstructured":"Watt PM, Hickson ID: Structure and function of type IIDNA topoisomerases. Biochem J 303: 681\u2013695, 1994","journal-title":"Biochem J"},{"key":"253401_CR23","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1083\/jcb.119.5.1023","volume":"119","author":"K Shiozaki","year":"1992","unstructured":"Shiozaki K, Yanagida M: Functional dissection of the phosphorylated termini of fission yeast DNA topoisomerase II. J Cell Biol 119: 1023\u20131036, 1992","journal-title":"J Cell Biol"},{"key":"253401_CR24","first-page":"3345","volume":"51","author":"SPC Cole","year":"1991","unstructured":"Cole SPC, Chanda ER, Dicke FP, Gerlach JH, Mirski SEL: Non-P-glycoprotein-mediated multidrug resistance in a small cell lung cancer cell line: evidence for decreased susceptibility to drug induced DNA damage and reduced levels of topoisomerase II. Cancer Res 51: 3345\u20133352, 1991","journal-title":"Cancer Res"},{"key":"253401_CR25","first-page":"1145","volume":"25","author":"Y Matsumoto","year":"1998","unstructured":"Matsumoto Y, Morisaki K, Kunishio K, Nagao S, Takano H, Fojo T: Incidence of mutation and deletion in topoisomerase II mRNA of etoposide and m-AMSA resistant cell lines. Jpn J Cancer Chemother 25: 1145\u20131149, 1998","journal-title":"Jpn J Cancer Chemother"},{"key":"253401_CR26","first-page":"2265","volume":"24","author":"Y Matsumoto","year":"1997","unstructured":"Matsumoto Y, Takano H, Nagao S, Iglesias A, Fojo T: Expression of DNA topoisomerases (I, II alpha, II beta) mRNA in etoposide-and mAMSA-resistant cell lines. Jpn J Cancer Chemother 24: 2265\u20132269, 1997","journal-title":"Jpn J Cancer Chemother"},{"key":"253401_CR27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/BF01058453","volume":"23","author":"Y Matsumoto","year":"1995","unstructured":"Matsumoto Y, Fujiwara T, Nagao S: Determinants of drug response in camptothechin-11-resistant glioma cell lines. J Neuro-Oncol 23: 1\u20138, 1995","journal-title":"J Neuro-Oncol"}],"container-title":["Journal of Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006346624083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1006346624083\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1006346624083.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T09:17:41Z","timestamp":1749633461000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1006346624083"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1999,1]]}},"alternative-id":["253401"],"URL":"https:\/\/doi.org\/10.1023\/a:1006346624083","relation":{},"ISSN":["0167-594X","1573-7373"],"issn-type":[{"type":"print","value":"0167-594X"},{"type":"electronic","value":"1573-7373"}],"subject":[],"published":{"date-parts":[[1999,1]]}}}